» Authors » Tarun Kumar Mittal

Tarun Kumar Mittal

Explore the profile of Tarun Kumar Mittal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 92
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mittal T, Evans E, Pottle A, Lambropoulos C, Morris C, Surawy C, et al.
Open Heart . 2022 May; 9(1). PMID: 35545356
Objective: The study evaluated the feasibility of mindfulness-based cognitive therapy (MBCT) in patients with non-cardiac chest pain by assessing their willingness to participate and adhere to the programme, and for...
2.
Mittal T, Reichmuth L, Bhattacharyya S, Jain M, Baltabaeva A, Haley S, et al.
Open Heart . 2019 Aug; 6(2):e001044. PMID: 31413845
Objectives: The aims of this study were to evaluate the inconsistency of aortic stenosis (AS) severity between CT aortic valve area (CT-AVA) and echocardiographic Doppler parameters, and to investigate potential...
3.
Szukiewicz D, Bilska A, Mittal T, Stangret A, Wejman J, Szewczyk G, et al.
BMC Pregnancy Childbirth . 2015 Sep; 15:220. PMID: 26377392
Background: Oxytocin (OXT) acts through its specific receptor (OXTR) and increased density of OXTR and/or augmented sensitivity to OXT were postulated as prerequisites of normal onset of labor. Expression of...
4.
Callington A, Long Q, Mohite P, Simon A, Mittal T
J Thorac Cardiovasc Surg . 2015 Jun; 150(3):696-704. PMID: 26092505
Objectives: To quantify the range of blood flow parameters in ascending aorta that can result from various angulations of outflow graft anastomosis of a left ventricular assist device (LVAD) to...
5.
Szukiewicz D, Wojciechowska M, Bilska A, Stangret A, Szewczyk G, Mittal T, et al.
Cardiovasc Drugs Ther . 2015 May; 29(3):219-29. PMID: 25959742
Purpose: TNF-α induces fractalkine (CX3CL1) and its receptor CX3CR1 in endothelial cells through NF-қB activation. NF-қB inhibitors may reduce the expression of CX3CL1, and modulation of the CX3CL1/CX3CR1 signaling was...
6.
Szukiewicz D, Kochanowski J, Mittal T, Pyzlak M, Szewczyk G, Cendrowski K
J Inflamm (Lond) . 2014 May; 11:12. PMID: 24851083
Background: Chemokine CX3CL1 possesses unique properties, including combined adhesive and chemotactic functions. Human amniotic epithelial cells (HAEC) show expression of CX3CL1 receptor (CX3CR1) and produce CX3CL1 in response to both...
7.
Szukiewicz D, Kochanowski J, Mittal T, Pyzlak M, Szewczyk G, Cendrowski K
Inflamm Res . 2013 Nov; 63(3):179-89. PMID: 24270813
Objective: Inflammation and hypoxia activate the fractalkine (CX3CL1) receptor (CX3CR1)-related signaling pathway. Tumor necrosis factor alpha (TNFα) induces CX3CL1, influencing a mechanism of CX3CL1 autoregulation by CX3CR1 expression. We compared...
8.
Szukiewicz D, Kochanowski J, Pyzlak M, Szewczyk G, Stangret A, Mittal T
Mediators Inflamm . 2013 Aug; 2013:437576. PMID: 23956503
Chemokine CX3CL1 is unique, possessing the ability to act as a dual agent: chemoattractant and adhesive compound. Acting via its sole receptor CX3CR1, CX3CL1 participates in many processes in human...